Your browser doesn't support javascript.
loading
Transient disappearance of CD19+/CD5+ B-lymphocyte clone in peripheral blood in a patient with CLL during SARS-CoV-2-related mild disease.
Barnabei, Remo; Di Michele, Giulio; Cellini, Antonio; Amicosante, Gianfranco; Perilli, Mariagrazia; Bellio, Pierangelo; Piccirilli, Alessandra; Celenza, Giuseppe.
Afiliação
  • Barnabei R; Clinical Laboratory Regional Hospital "San Salvatore" L'Aquila Italy.
  • Di Michele G; Clinical Laboratory Regional Hospital "San Salvatore" L'Aquila Italy.
  • Cellini A; Department of Infectious Diseases and AIDS Regional Hospital "San Salvatore" L'Aquila Italy.
  • Amicosante G; Department of Biotechnological and Applied Clinical Sciences University of L'Aquila L'Aquila Italy.
  • Perilli M; Department of Biotechnological and Applied Clinical Sciences University of L'Aquila L'Aquila Italy.
  • Bellio P; Department of Biotechnological and Applied Clinical Sciences University of L'Aquila L'Aquila Italy.
  • Piccirilli A; Department of Biotechnological and Applied Clinical Sciences University of L'Aquila L'Aquila Italy.
  • Celenza G; Department of Biotechnological and Applied Clinical Sciences University of L'Aquila L'Aquila Italy.
Clin Case Rep ; 9(6): e04238, 2021 Jun.
Article em En | MEDLINE | ID: mdl-34188925
Although lymphopenia is currently considered a good predictor for the prognosis of COVID-19, it must be critically evaluated in patients with CLL, where other clinical markers should be considered to define the prognosis and treatment.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Clin Case Rep Ano de publicação: 2021 Tipo de documento: Article País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Clin Case Rep Ano de publicação: 2021 Tipo de documento: Article País de publicação: Reino Unido